Articles by Daniel Marsh
FTSE 100 Passive Income: Calculating Investment for £3,000 Annual Yield
To generate £3,000 passive income from FTSE 100 dividends, invest £96,775 at current 3.1% yield or £50,000 in high-yield stocks averaging 6%.
NCR Voyix Surges 10% on Turnaround Optimism
NCR Voyix surged 10.25% to $7.85, far outpacing the market, as investors focus on 2026 cash-flow and earnings targets. The Q2 2026 earnings update is the next key catalyst.
Redwire Shares Tumble on $500M ATM Dilution Fears; Space Sector Rotates
Redwire shares plunged 11.6% on heavy volume after unveiling a $500 million ATM equity program, sparking dilution fears amid a broader rotation out of smaller space stocks following SpaceX's market debut.
Rocket Lab Shares Sink Despite Nasdaq-100 Inclusion, SpaceX Debut Pressures Sector
Rocket Lab shares dropped 10.79% to $102.39 despite joining the Nasdaq-100, as profit-taking and the SpaceX IPO weighed on space stocks. The index inclusion is set for June 22, with attention turning to Q2 earnings and Neutron progress.
SMCI Stock Drops as $7B Financing Plan Raises Dilution Concerns
Super Micro Computer shares slid 4.7% after pricing a $7 billion financing package, raising dilution concerns. The company aims to support $39 billion in AI server orders.
Nokia Oyj Surges 10% Following JPMorgan Upgrade
Nokia Oyj shares surged 10% to €12.97 after JPMorgan upgraded its price target to €18, highlighting AI and cloud potential. The stock was the top performer on the OMX Helsinki 25.
American Airlines Gains on Falling Oil Prices and Route Expansion
American Airlines shares climbed on Friday, buoyed by a drop in oil prices and the announcement of new international routes from its Miami hub.
Social Security 2027 COLA Estimate Climbs to 3.8% on Sticky Inflation
The Senior Citizens League now estimates a 3.8% Social Security COLA for 2027, driven by May's 4.4% CPI-W jump. This would boost average monthly benefits by $77.
Trade Desk Shares Recover After Publicis Settlement, Yet Growth Hurdles Loom
The Trade Desk shares gained 2.01% after settling a dispute with Publicis, removing a key overhang, but the stock still trades near its 52-week low as Q2 results approach.
Alumis Stock Jumps 15.6% on Strong Analyst Support and Psoriasis Trial Results
Alumis shares jumped 15.55% on double average volume, driven by strong analyst support and late-stage psoriasis data. The company remains high-risk with no approved products.